PATENT CLAIM ANALYSIS

Application Number: 15907056
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-10
Patent Classification: ["424", "186100"]

Abstract:
This document provides methods and materials involved in using measles viruses. For example, methods and materials for identifying mammals (e.g., humans) likely to respond to standard measles virus vaccines or standard measles virus-based therapies as well as methods and materials for identifying mammals (e.g., humans) unlikely to respond to standard measles virus vaccines or standard measles virus-based therapies are provided.

Claim (Index 6):
The method of  claim 4 , wherein said method comprises administering said enhanced measles virus vaccine, and wherein said enhanced measles virus vaccine comprises adjuvants having the ability to increase surface expression of CD46 or upregulation of IFI44L.

Metadata:
- Claim Count in Document: 3.0
- Percentile: 88.0
- Lexical Diversity: 1.91667
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['12993693', '11266957', '12507163', '12219570', '13980392']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7429741788206954
- 35 USC 102 Novelty (BERT): 0.5045300248800441
- Combined Prediction Score: 0.7191297634266303
- Mean Citation Score: 255.579404
- Max Citation Score: 265.13614
- Similarity Product: 195.02453473399163

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test